Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C.
暂无分享,去创建一个
Mario Plebani | A. Alberti | G. Sebastiani | M. Plebani | Giada Sebastiani | Alfredo Alberti | F. Noventa | A. Vario | M. Guido | R. Pistis | A. Ferrari | Alessandro Vario | Maria Guido | Franco Noventa | Roberta Pistis | Alessia Ferrari
[1] R. Robinson. Economic Evaluation and Health Care Cost-effectiveness analysis , 2006 .
[2] Plumley Pf. Letter: the consultants' contract. , 1975, Lancet.
[3] E. Schiff,et al. The role of laparoscopy in the diagnosis of cirrhosis. , 1996, Gastrointestinal endoscopy.
[4] L. Seeff,et al. Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .
[5] Llorenç Quintó,et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.
[6] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[7] V. de Lédinghen,et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. , 2005, Gastroenterology.
[8] K. Reddy,et al. Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels. , 2004, Gastroenterology.
[9] J. Wong,et al. Watchful Waiting with Periodic Liver Biopsy versus Immediate Empirical Therapy for Histologically Mild Chronic Hepatitis C: A Cost-Effectiveness Analysis , 2000, Annals of Internal Medicine.
[10] G. Leandro,et al. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. , 2003, Journal of hepatology.
[11] W. Taylor,et al. LIVER BIOPSY: COMPLICATIONS IN 1000 INPATIENTS AND OUTPATIENTS , 1978 .
[12] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[13] R. Wiesner,et al. Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. , 2002 .
[14] N. Afdhal,et al. Evaluation of Liver Fibrosis: A Concise Review , 2004, American Journal of Gastroenterology.
[15] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[16] R. Stauber,et al. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C , 2005, Hepatology.
[17] Samer S El-Kamary,et al. Role of liver biopsy in management of chronic hepatitis C: A systematic review , 2002, Hepatology.
[18] H. T. Head,et al. Global surveillance and control of hepatitis C , 1999 .
[19] 克也 平山,et al. A prospective randomized trial , 1995 .
[20] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[21] M. Ziol,et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. , 2003, Ultrasound in medicine & biology.
[22] A. Alberti. Towards more individualised management of hepatitis C virus patients with initially or persistently normal alanineaminotransferase levels. , 2005, Journal of hepatology.
[23] K. Ishak,et al. Chronic hepatitis: morphology and nomenclature. , 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[24] B. Maharaj,et al. SAMPLING VARIABILITY AND ITS INFLUENCE ON THE DIAGNOSTIC YIELD OF PERCUTANEOUS NEEDLE BIOPSY OF THE LIVER , 1986, The Lancet.
[25] P. Marcellin,et al. Therapy of hepatitis C: Patients with normal aminotransferase levels , 1997, Hepatology.
[26] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.
[27] D. Thabut,et al. Noninvasive prediction of fibrosis in patients with chronic hepatitis C , 2003, Hepatology.
[28] D. Thabut,et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. , 2004, Clinical chemistry.
[29] A. Alberti,et al. Natural history of hepatitis C. , 1999, Journal of hepatology.
[30] Enrico Rossi,et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. , 2003, Clinical chemistry.
[31] D. Thabut,et al. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C , 2004, Hepatology.
[32] M. Spinello,et al. Percutaneous blind biopsy versus laparoscopy with guided biopsy in diagnosis of cirrhosis , 2005, Digestive Diseases and Sciences.
[33] J Rakela,et al. The role of ultrasonography and automatic‐needle biopsy in outpatient percutaneous liver biopsy , 1996, Hepatology.
[34] J. Pawlotsky,et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. , 2004, Journal of hepatology.